Ipca Laboratories, through its wholly owned subsidiary Ipca Laboratories UK has acquired 100% stake in Onyx Research Chemical, holding company of Onyx Scientific. The acquisition brings together two contract manufacturing organization (CMOs) to better serve their customers on a global basis.
Onyx Scientific has been a chemistry solution provider for over a decade and will continue to operate out of the Silverbriar (Sunderland, UK) facility under the Onyx Scientific trade name. Onyx’s capabilities in chemistry services for medicinal, preclinical and phase -I/II programs will dovetail effectively with Ipca’s capabilities in supporting phase II to commercial scale programmes.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1818.55 |
| Dr. Reddys Lab | 1278.00 |
| Cipla | 1327.95 |
| Zydus Lifesciences | 908.35 |
| Lupin | 2336.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: